Jason P Rhodes has an estimated net worth of $98.4 Million. This is based on reported shares across multiple companies, which include Dyne Therapeutics, Inc., Generation Bio Co., Replimune Group, Inc., Gemini Therapeutics, Inc. /DE, and Epizyme, Inc..

2014 was Jason P Rhodes's most active year for acquiring shares with 17 total transactions. Jason P Rhodes's most active month to acquire stocks was the month of May. 2020 was Jason P Rhodes's most active year for disposing of shares, totalling 74 transactions. Jason P Rhodes's most active month to dispose stocks was the month of November. 2025 saw Jason P Rhodes paying a total of $14,999,998.50 for 1,176,111 shares, this is the most they've acquired in one year. In 2024 Jason P Rhodes cashed out on 1,866,095 shares for a total of $44,258,206.57, their largest year based on trade value.